WELL Health Technologies Corp. revised revenue guidance for the year 2024. The company increases its guidance range for 2024 annual revenue of between $960 million to $980 million.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.81 CAD | -1.30% | -2.81% | -1.04% |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.04% | 681M | |
+19.28% | 84.56B | |
-26.95% | 72.41B | |
+4.58% | 27.73B | |
-7.35% | 17.75B | |
-0.46% | 17.11B | |
+4.69% | 16.03B | |
+8.14% | 13.72B | |
+69.96% | 13.07B | |
+6.59% | 12.91B |
- Stock Market
- Equities
- WELL Stock
- News WELL Health Technologies Corp.
- WELL Health Technologies Corp. Revises Revenue Guidance for the Year 2024